COL1A2 was associated with poor outcomes in GBM and validated to be significantly linked to poor prognosis in both TCGA and CGGA database,48 as well as our study, so the over expression of COL1A2 might be important to the development of GBM. This evidence concerns the gene COL1A2 and glioblastoma.